Bridging Duration for Enoxaparin (Coexane) When Restarting Warfarin
Continue therapeutic-dose enoxaparin until the INR reaches the therapeutic range (≥2.0) on two consecutive measurements, which typically requires 4-8 days after warfarin resumption. 1, 2
Warfarin Restart Timing
Restart warfarin within 24 hours after the procedure (typically the evening of surgery) once adequate hemostasis is established 1, 2. The FDA label confirms warfarin can be restarted as early as day 1 postoperatively 3.
- For low bleeding risk procedures: restart at 24-48 hours post-procedure
- For high bleeding risk procedures: restart at 48-72 hours post-procedure
- Resume at the patient's usual maintenance dose (not doubled) 2
Enoxaparin Bridging Protocol After Warfarin Restart
Initial Post-Procedure Phase
When bridging with LMWH is used, restart enoxaparin after hemostasis is established 1:
- Start with prophylactic dosing for the first 24-72 hours post-procedure
- Then increase to therapeutic dosing (1 mg/kg subcutaneously every 12 hours, or 1 mg/kg daily if CrCl <30 mL/min) 4, 5
- Continue therapeutic-dose enoxaparin until warfarin achieves therapeutic effect
Duration Until Warfarin is Therapeutic
Continue enoxaparin until INR is within the target therapeutic range on 2 separate measurements 1, 6, 3. This overlap period typically requires:
- 4-5 days minimum overlap with full-dose heparin/enoxaparin therapy 3
- Warfarin takes 2-3 days for partial anticoagulant effect and 4-8 days for full anticoagulant effect 2
- The FDA label emphasizes continuing overlap until warfarin produces the desired therapeutic response as determined by PT/INR 3
Practical Timeline Example
For a patient undergoing a high-risk procedure:
- Day 0 (surgery day): Restart warfarin that evening with usual dose
- Day 1-3 post-op: Enoxaparin at prophylactic dose (if bleeding risk allows)
- Day 3 onwards: Increase enoxaparin to therapeutic dose (1 mg/kg every 12 hours)
- Day 4-8: Continue therapeutic enoxaparin while checking INR
- Discontinue enoxaparin: Only when INR ≥2.0 on two consecutive measurements
Critical Considerations
High thrombotic risk patients (CHADS₂ score ≥3, mechanical heart valve, stroke/TIA within 3 months, rheumatic heart disease) require this full bridging protocol 1. The 2022 CHEST guidelines strongly recommend this approach for mechanical heart valves 2.
Renal function matters: Reduce enoxaparin to 1 mg/kg once daily if creatinine clearance <30 mL/min 4, 5. In severe renal impairment, consider unfractionated heparin instead 6.
Common pitfall: Stopping enoxaparin too early before warfarin achieves full anticoagulant effect leaves patients vulnerable during the 4-8 day warfarin onset period. The two-measurement INR confirmation prevents premature discontinuation 3.
Research data supports this approach, with studies showing mean bridging durations of 7-19.5 days depending on when therapeutic INR is achieved 7, 8, 9. The key is not a fixed duration, but rather continuation until documented therapeutic anticoagulation with warfarin.